Marianna Rossi

Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial

Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka et al. · Blood · 2014 · 507 citations

Medicine, Genetics, Oncology +17

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation

Matteo Giovanni Della Porta, Anna Gallì, Andrea Bacigalupo et al. · Journal of Clinical Oncology · 2016 · 255 citations · Full text

Medicine, Hematology, Molecular Genetics +17

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer et al. · Journal of Clinical Oncology · 2021 · 225 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial

Peter Dreger, Andrea Schnaiter, Thorsten Zenz et al. · Blood · 2013 · 105 citations · Full text

Medicine, Hematology, Oncology +13

NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG

Andrea Schnaiter, Peter Paschka, Marianna Rossi et al. · Blood · 2013 · 77 citations

Medicine, Oncology, Pharmacotherapy +14